Prostacyclin Analogues Inhibit Platelet Reactivity, Extracellular Vesicle Release and Thrombus Formation in Patients with Pulmonary Arterial Hypertension.

extracellular vesicles platelet reactivity prostacyclin analogues pulmonary arterial hypertension thrombus formation

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
02 Mar 2021
Historique:
received: 14 01 2021
revised: 12 02 2021
accepted: 19 02 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 4 4 2021
Statut: epublish

Résumé

(1) Background: Prostacyclin analogues (epoprostenol, treprostinil, and iloprost) induce vasodilation in pulmonary arterial hypertension (PAH) but also inhibit platelet function. (2) Objectives: We assessed platelet function in PAH patients treated with prostacyclin analogues and not receiving prostacyclin analogues. (3) Methods: Venous blood was collected from 42 patients treated with prostacyclin analogues (49.5 ± 15.9 years, 81% female) and 38 patients not receiving prostacyclin analogues (55.5 ± 15.6 years, 74% female). Platelet reactivity was analyzed by impedance aggregometry using arachidonic acid (AA; 0.5 mM), adenosine diphosphate (ADP; 6.5 µM), and thrombin receptor-activating peptide (TRAP; 32 µM) as agonists. In a subset of patients, concentrations of extracellular vesicles (EVs) from all platelets (CD61

Identifiants

pubmed: 33801460
pii: jcm10051024
doi: 10.3390/jcm10051024
pmc: PMC7958838
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Narodowe Centrum Nauki
ID : 2018/31/N/NZ7/02260
Organisme : Centre of Postgraduate Medical Education, Warsaw, Poland
ID : 501-1-54-25-18
Organisme : Nederlandse Organisatie voor Wetenschappelijk Onderzoek
ID : VENI 15924

Références

J Biol Chem. 1993 Jul 15;268(20):14586-9
pubmed: 8325838
Pulm Circ. 2012 Oct;2(4):518-21
pubmed: 23372937
Respir Res. 2016 Oct 20;17(1):133
pubmed: 27765042
Nanomedicine. 2018 Apr;14(3):801-810
pubmed: 29307842
Platelets. 2017 May;28(3):228-234
pubmed: 27996341
Kardiol Pol. 2015;73(1):63-8
pubmed: 25625343
J Thromb Haemost. 2010 Nov;8(11):2571-4
pubmed: 20831623
Eur Respir J. 2015 Oct;46(4):903-75
pubmed: 26318161
Br J Pharmacol. 1978 Jul;63(3):535-9
pubmed: 352466
J Thromb Haemost. 2020 Mar;18(3):609-623
pubmed: 31833175
Platelets. 2019;30(7):893-900
pubmed: 30365350
Pulm Circ. 2019 Sep 11;9(3):2045894019875342
pubmed: 31588353
Sci Rep. 2017 Jul 17;7(1):5582
pubmed: 28717253
Eur Respir J. 2013 Jul;42(1):272-9
pubmed: 23258792
J Clin Invest. 2012 Dec;122(12):4306-13
pubmed: 23202738
Circ Res. 2017 May 12;120(10):1632-1648
pubmed: 28495994
J Thromb Haemost. 2018 Jun;16(6):1236-1245
pubmed: 29575716
Pediatr Pulmonol. 2019 Jan;54(1):66-72
pubmed: 30485728
Cell Commun Signal. 2019 Nov 8;17(1):143
pubmed: 31703702
Thromb Res. 2011 Nov;128(5):446-51
pubmed: 21624644
J Thromb Haemost. 2018 May 26;:
pubmed: 29802795
Am J Respir Crit Care Med. 2008 Jun 1;177(11):1268-75
pubmed: 18310479
J Extracell Vesicles. 2019 Jul 25;8(1):1643671
pubmed: 31489142
Drug Discov Today. 2014 Aug;19(8):1230-5
pubmed: 24747560
Int J Cardiol. 2017 Jan 1;226:93-102
pubmed: 27792994
Int J Mol Sci. 2020 Nov 27;21(23):
pubmed: 33260972
Eur Respir J. 2002 Mar;19(3):518-24
pubmed: 11936532
Blood. 1979 Feb;53(2):244-50
pubmed: 367465
Pathophysiol Haemost Thromb. 2002 Jan-Feb;32(1):16-24
pubmed: 12214159
Platelets. 2020;31(1):26-32
pubmed: 30585111
Cardiol J. 2019;26(6):782-789
pubmed: 29671861
Platelets. 2019;30(5):646-651
pubmed: 30047809
Circ J. 2005 Feb;69(2):216-20
pubmed: 15671616
Int J Mol Sci. 2020 Aug 23;21(17):
pubmed: 32842470
Pharmacol Ther. 1996;72(3):171-91
pubmed: 9364574
Anaesth Intensive Care. 1997 Aug;25(4):343-6
pubmed: 9288373
Int J Impot Res. 2007 Mar-Apr;19(2):139-48
pubmed: 16761012
Mol Cell Biol. 2013 Jan;33(2):184-93
pubmed: 23109431
Haemostasis. 1984;14(6):487-94
pubmed: 6442909
FASEB J. 2003 Mar;17(3):476-8
pubmed: 12514112
J Heart Lung Transplant. 2009 Oct;28(10):1081-6
pubmed: 19782291
J Extracell Vesicles. 2020 Feb 3;9(1):1713526
pubmed: 32128070
BMC Pulm Med. 2017 Dec 2;17(1):162
pubmed: 29195500
Eur J Clin Invest. 2013 Jan;43(1):64-71
pubmed: 23176388
Nat Rev Cardiol. 2011 Jun 21;8(8):443-55
pubmed: 21691314
Br J Pharmacol. 2019 Apr;176(8):1038-1050
pubmed: 29468666
Thromb Res. 2020 Nov;195:120-124
pubmed: 32683150

Auteurs

Aleksandra Gąsecka (A)

1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland.
Laboratory of Experimental Clinical Chemistry and Vesicle Observation Centre, Amsterdam University Medical Centre, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.

Marta Banaszkiewicz (M)

Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, European Health Centre Otwock, 05-400 Otwock, Poland.

Rienk Nieuwland (R)

Laboratory of Experimental Clinical Chemistry and Vesicle Observation Centre, Amsterdam University Medical Centre, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.

Edwin van der Pol (E)

Laboratory of Experimental Clinical Chemistry and Vesicle Observation Centre, Amsterdam University Medical Centre, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Biomedical Engineering and Physics, Amsterdam University Medical Centre, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.

Najat Hajji (N)

Laboratory of Experimental Clinical Chemistry and Vesicle Observation Centre, Amsterdam University Medical Centre, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.

Hubert Mutwil (H)

1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland.

Sylwester Rogula (S)

1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland.

Wiktoria Rutkowska (W)

1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland.

Kinga Pluta (K)

1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland.

Ceren Eyileten (C)

Department of Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology, Medical University of Warsaw, 02-091 Warsaw, Poland.

Marek Postuła (M)

Department of Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology, Medical University of Warsaw, 02-091 Warsaw, Poland.

Szymon Darocha (S)

Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, European Health Centre Otwock, 05-400 Otwock, Poland.

Zenon Huczek (Z)

1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland.

Grzegorz Opolski (G)

1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland.

Krzysztof J Filipiak (KJ)

1st Chair and Department of Cardiology, Medical University of Warsaw, 02-097 Warsaw, Poland.

Adam Torbicki (A)

Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, European Health Centre Otwock, 05-400 Otwock, Poland.

Marcin Kurzyna (M)

Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, European Health Centre Otwock, 05-400 Otwock, Poland.

Classifications MeSH